1-8 of 8
Henry Chan, MBChB
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Zanubrutinib in Patients with Relapsed/Refractory Marginal Zone Lymphoma: Initial Results of the MAGNOLIA (BGB-3111-214) Trial

Free
Stephen Opat, FRACP, FRCPA, MBBS, Alessandra Tedeschi, MD, Kim Linton, MBChB, MRCP, PhD, Pamela McKay, MBChB (Hons), FRCP, FRCPath, Bei Hu, MD, Henry Chan, MBChB, FRACP, FRCPA, Jie Jin, MD PhD, Pier Luigi Zinzani, MD, Peter Browett, BMedSci, MBChB, FRACP, FRCPA, Morton Coleman, MD, Magdalena Sobieraj-Teague, MBBS, FRACP, FRCPA, M.Sc, Xiaoyan Ke, MD PhD, Mingyuan Sun, MD, Robert Marcus, MA, FRCP, FRCPath, Craig A. Portell, MD, Keshu Zhou, MD PhD, Catherine Thieblemont, MD PhD, Melannie Co, MD, Weige Wang, MD, Chris Tankersley, BS, Wenxiao Zhou, M.Sc, Massimo Cappellini, BS, Jane Huang, MD, Judith Trotman, MBChB, FRACP, FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–30.
https://doi.org/10.1182/blood-2020-134611
Published: 2020
Journal Articles

Efficacy and Safety of Zanubrutinib in Patients with Treatment-Naïve (TN) Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) with del(17p): Follow-up Results from Arm C of the SEQUOIA (BGB-3111-304) Trial

Free
Jennifer R. Brown, MD PhD, Tadeusz Robak, MDPhD, Paolo Ghia, MD PhD, Brad S. Kahl, MD, Patricia Walker, MBBS, BMedSci, FRACP, FRCPA, Wojciech Janowski, MBChB, FRCPA, FRACP, Henry Chan, MBChB, FRACP, FRCPA, Mazyar Shadman, MD MPH, Peter S. Ganly, BMBCh, PhD, Luca Laurenti, MD, Stephen Opat, MBBS (Hons), FRACP, FRCPA, Monica Tani, MD, Hanna Ciepluch, MD, Emma Verner, MBBS, BMedSci,FRCPA, FRACP, Martin Šimkovič, MD PhD, Anders Österborg, MD PhD, Marek Trněný, MD, Alessandra Tedeschi, MD, Piers Blombery, MBBS, Jason C. Paik, MD PhD, Fangfang Yin, PhD, Shibao Feng, PhD, Vanitha Ramakrishnan, PhD, Jane Huang, MD, Peter Hillmen, MBChB, PhD FRCP, FRCPath, Constantine S. Tam, MBBS, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-134280
Published: 2020
Journal Articles

Bortezomib Induction and Consolidation in Patients with Multiple Myeloma Who Received Frontline Autologous Stem Cell Transplant

Free
Sarah Ai Ting Tan, Steven Shih, MBChB, Scarlett Olasope, MBChB, Sharon R. Jackson, FRACP, FRCPA, Sarah Poplar, MBChB,FRCPath,FRPATH,PGCert,MRCP,ClinEd, Henry Chan, MBChB, FRACP, FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 33.
https://doi.org/10.1182/blood-2020-140077
Published: 2020
Journal Articles

Epidemiology of Acute Myeloid Leukaemia in New Zealand: A National Cancer Registry Analysis

Free
Henry Chan, MBChB, FRACP, FRCPA, Alana Cavadino, BSc, MSc, PhD, Clinton Lewis, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-136524
Published: 2020
Journal Articles

Conservative Management of Hemochromatosis without Long-Term Maintenance Venesections in Patients with Moderate Iron Burden

Free
Jenny Sumin Yoon, MBChB, Ross Alistair Henderson, MBChB FRACP FRCPA PhD, Merit Hanna, MBChB FRCPA, Eileen Merriman, MBChB BMLSc FRACP FRCPA PhD, Anna Elinder, MBChB FRACP FRCPA, Gilly Selman, MLS, Leone Kennedy, BN PGCertHSc, Henry Chan, MBChB, FRACP, FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-136534
Published: 2020
Journal Articles

ME-401-003 (TIDAL): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Phase 2 Study of ME-401 Investigating Continuous and Intermittent Dosing Schedules in Patients with Relapsed/Refractory Follicular Lymphoma

Free
Andrew D. Zelenetz, MD PhD, Pier Luigi Luigi Zinzani, MD, Henry Chan, MBChB, Christian Buske, MD PhD, Vincent Ribrag, David Cunningham, MD FRCP, FMedSci, Wojciech Jurczak, Pau Abrisqueta, MD PhD, Joanne Li, Igor Gorbatchevsky, MD, Jennifer R. Brown, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5244.
https://doi.org/10.1182/blood-2019-124326
Published: 2019
Journal Articles

Single Centre Experience in Treating Elderly Patients with Acute Myeloid Leukaemia or High Risk Myelodysplastic Syndrome with a Combination of Low Dose Cytarabine, Venetoclax and Fluconazole (VeLDAC-F)

Free
Lauren Child, Henry Chan, MBChB, Ross Alistair Henderson, PhD MBChB, Anna Elinder, MBChB, Eileen Merriman, MBChB, Merit Hanna, MBChB, David Simpson, MBChB, FRACP, FRCPA
Journal: Blood
Blood (2018) 132 (Supplement 1): 5220.
https://doi.org/10.1182/blood-2018-99-115993
Published: 2018
Journal Articles

Fixed Dose Carfilzomib Triplets in Lenalidomide Refractory Myeloma

Free
David Simpson, MBChB, FRACP, FRCPA, Henry Chan, MBChB
Journal: Blood
Blood (2018) 132 (Supplement 1): 3306.
https://doi.org/10.1182/blood-2018-99-110891
Published: 2018